Idogen: Finds a way forward

Research Note

2019-06-18

10:13

Idogen shares soar roughly 40% following today’s announcement that they have established a new method for the development of their dendritic cell therapy. While it is still early stage, we have a positive view on today's news.

LS

Ludvig Svensson

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.